T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Zoom
ZM
|
+$2.88B |
| 2 |
Eli Lilly
LLY
|
+$2.63B |
| 3 |
AstraZeneca
AZN
|
+$1.96B |
| 4 |
Fortinet
FTNT
|
+$1.66B |
| 5 |
Coupang
CPNG
|
+$1.63B |
Top Sells
| 1 |
NXP Semiconductors
NXPI
|
+$2.58B |
| 2 |
Morgan Stanley
MS
|
+$2.29B |
| 3 |
Airbnb
ABNB
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.8B |
| 5 |
Qualcomm
QCOM
|
+$1.79B |
Sector Composition
| 1 | Technology | 23.37% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Cheesecake Factory
CAKE
$2.82B
| $1.63M | ﹤0.01% |
27,931
-319
| -1% | -$18.7K |
|
1802
Navient
NAVI
$1.28B
| $1.63M | ﹤0.01% |
114,163
+7,158
| +7% | +$102K |
|
|
BCPC
1803
Balchem Corporation
BCPC
$5.07B
| $1.63M | ﹤0.01% |
13,026
+104
| +0.8% | +$13K |
|
1804
OraSure Technologies
OSUR
$242M
| $1.61M | ﹤0.01% |
138,266
-9,638
| -7% | -$113K |
|
1805
Evercore
EVR
$13.2B
| $1.61M | ﹤0.01% |
12,242
+279
| +2% | +$36.8K |
|
1806
Check Point Software Technologies
CHKP
$21B
| $1.61M | ﹤0.01% |
14,373
+4
| +0% | +$448 |
|
1807
Cassava Sciences
SAVA
$102M
| $1.61M | ﹤0.01% |
35,706
+22,209
| +165% | +$998K |
|
1808
Ashland
ASH
$2.41B
| $1.6M | ﹤0.01% |
18,024
+2,562
| +17% | +$227K |
|
1809
Ultra Clean Holdings
UCTT
$1.14B
| $1.59M | ﹤0.01% |
27,420
+10,422
| +61% | +$605K |
|
1810
Amkor Technology
AMKR
$6.29B
| $1.58M | ﹤0.01% |
66,748
-15,577
| -19% | -$369K |
|
1811
NBT Bancorp
NBTB
$2.27B
| $1.58M | ﹤0.01% |
39,548
-9
| -0% | -$359 |
|
1812
KBR
KBR
$6.36B
| $1.58M | ﹤0.01% |
41,058
+5,286
| +15% | +$203K |
|
1813
Sally Beauty Holdings
SBH
$1.48B
| $1.57M | ﹤0.01% |
77,826
+10,407
| +15% | +$210K |
|
1814
Enpro
NPO
$4.64B
| $1.57M | ﹤0.01% |
18,359
-213,071
| -92% | -$18.2M |
|
1815
CryoPort
CYRX
$433M
| $1.56M | ﹤0.01% |
30,046
+7,166
| +31% | +$373K |
|
1816
Fresenius Medical Care
FMS
$14.7B
| $1.56M | ﹤0.01% |
+42,352
| New | +$1.56M |
|
1817
Ligand Pharmaceuticals
LGND
$3.23B
| $1.56M | ﹤0.01% |
16,423
-85,877
| -84% | -$8.17M |
|
|
RWT
1818
Redwood Trust
RWT
$804M
| $1.56M | ﹤0.01% |
149,636
+14,574
| +11% | +$152K |
|
1819
Rithm Capital
RITM
$6.57B
| $1.56M | ﹤0.01% |
138,444
+7,156
| +5% | +$80.5K |
|
1820
Cannae Holdings
CNNE
$1.11B
| $1.55M | ﹤0.01% |
39,223
-726,498
| -95% | -$28.8M |
|
1821
City Holding Co
CHCO
$1.83B
| $1.55M | ﹤0.01% |
18,976
-2,028
| -10% | -$166K |
|
1822
Milestone Pharmaceuticals
MIST
$167M
| $1.55M | ﹤0.01% |
267,997
-106,960
| -29% | -$619K |
|
1823
Hovnanian Enterprises
HOV
$895M
| $1.55M | ﹤0.01% |
14,667
-4,080
| -22% | -$431K |
|
|
WWE
1824
DELISTED
World Wrestling Entertainment
WWE
| $1.55M | ﹤0.01% |
28,471
-3,890
| -12% | -$211K |
|
1825
ATI
ATI
$10.5B
| $1.54M | ﹤0.01% |
73,109
+18,222
| +33% | +$384K |
|